Kintor Pharmaceutical Limited
KNTPF
Price:
$0.216
Market Cap:
$789.55M
Kintor Pharmaceutical Limited, a clinical-stage biotechnology company, engages in developing and commercializing a pipeline of small molecule and biological therapeutics for androgen-receptor-related disease areas with unmet medical needs in the People's Republic of China and internationally. The company's products pipeline include Proxalutamide, a second generation androgen receptor (AR) antagonist for the treatment of metastatic castration-resistant prostate cancer, AR positive breast cancer, and COVID-19; and Pyrilutamide, an AR antagonist for the androgenetic alopecia (AGA) and acne vulgaris treatment. Its products pipeline also comprise ALK-1 antibody for the treatment of metastatic hep...[Read more]
Industry
Biotechnology
IPO Date
2020-12-11
Stock Exchange
OTC
Ticker
KNTPF
PE Ratio
[-4.32]
ROE
[0%]
Current Ratio
[0.44]
Dividend Yield
[0%]
Enterprise Value
[824.09M]
Dividend History
The ROE as of December 2025 (TTM) for Kintor Pharmaceutical Limited (KNTPF) is 0%
According to Kintor Pharmaceutical Limited’s latest financial reports and current stock price. The company's current ROE is 0%. This represents a change of -100.00% compared to the average of -0.05% of the last 4 quarters.
Kintor Pharmaceutical Limited (KNTPF) Historical ROE (quarterly & annually)
How has KNTPF ROE performed in the past?
The mean historical ROE of Kintor Pharmaceutical Limited over the last ten years is -268.59%. The current 0% ROE has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), KNTPF's ROE was at its highest in in the December 2014 quarter at 0%. The ROE was at its lowest in in the December 2017 quarter at -0.64%.
Average
-268.59%
Median
-58.32%
Minimum
-1272.89%
Maximum
-0.43%
Kintor Pharmaceutical Limited (KNTPF) ROE by Quarter and Year
Discovering the peaks and valleys of Kintor Pharmaceutical Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 145.86%
Maximum Annual ROE = -0.43%
Minimum Annual Increase = -99.97%
Minimum Annual ROE = -1272.89%
| Year | ROE | Change |
|---|---|---|
| 2024 | -52.81% | -77.20% |
| 2023 | -231.56% | 262.79% |
| 2022 | -63.83% | 25.46% |
| 2021 | -50.88% | 50.93% |
| 2020 | -33.71% | -94.64% |
| 2019 | -629.16% | 145.86% |
| 2018 | -0.43% | -99.97% |
| 2017 | -1272.89% | 295.52% |
| 2016 | -321.83% | 1.02% |
| 2015 | -28.80% | -54.97% |
Kintor Pharmaceutical Limited (KNTPF) Average ROE
How has KNTPF ROE performed in the past?
The current ROE of Kintor Pharmaceutical Limited (KNTPF) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-116.07%
5-year avg
-86.56%
10-year avg
-268.59%
Kintor Pharmaceutical Limited (KNTPF) ROE vs. Peers
How is KNTPF’s ROE compared to its peers?
Kintor Pharmaceutical Limited’s ROE is greater than Paradigm Biopharmaceuticals Limited (-67.96%), greater than Poolbeg Pharma PLC (-53.86%), less than Nuo Therapeutics, Inc. (1.03%), greater than Hofseth BioCare ASA (-279.05%), greater than Imugene Limited (-127.46%), greater than Satellos Bioscience Inc. (-51.42%), less than Scancell Holdings plc (126.94%), less than Shield Therapeutics plc (206.44%), less than VitaSpring Biomedical Co. Ltd. (128.70%), greater than Innate Pharma S.A. (-658.91%),
| Company | ROE | Market cap |
|---|---|---|
| -67.96% | $109.88M | |
| -53.86% | $29.63M | |
| 1.03% | $108.66M | |
| -279.05% | $66.68M | |
| -127.46% | $57.72M | |
| -51.42% | $87.00M | |
| 126.94% | $140.10M | |
| 206.44% | $95.67M | |
| 128.70% | $207.03M | |
| -658.91% | $183.43M |
Build a custom stock screener for Kintor Pharmaceutical Limited (KNTPF) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kintor Pharmaceutical Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Kintor Pharmaceutical Limited (KNTPF) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Kintor Pharmaceutical Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Kintor Pharmaceutical Limited's ROE?
How is the ROE calculated for Kintor Pharmaceutical Limited (KNTPF)?
What is the highest ROE for Kintor Pharmaceutical Limited (KNTPF)?
What is the 3-year average ROE for Kintor Pharmaceutical Limited (KNTPF)?
What is the 5-year average ROE for Kintor Pharmaceutical Limited (KNTPF)?
How does the current ROE for Kintor Pharmaceutical Limited (KNTPF) compare to its historical average?